Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

SCD1 regulates the AMPK/SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle.

Dziewulska A, Dobosz AM, Dobrzyn A, Smolinska A, Kolczynska K, Ntambi JM, Dobrzyn P.

J Cell Physiol. 2019 Jun 26. doi: 10.1002/jcp.29026. [Epub ahead of print]

PMID:
31241768
2.

Exhaled Volatile Organic Compounds are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.

Schleich FN, Zanella D, Stefanuto PH, Bessonov K, Smolinska A, Dallinga JW, Henket M, Paulus V, Guissard F, Graff S, Moermans C, Wouters EFM, Van Steen K, van Schooten FJ, Focant JF, Louis R.

Am J Respir Crit Care Med. 2019 Apr 11. doi: 10.1164/rccm.201811-2210OC. [Epub ahead of print]

PMID:
30973757
3.

Comparing patterns of volatile organic compounds exhaled in breath after consumption of two infant formulae with a different lipid structure: a randomized trial.

Smolinska A, Baranska A, Dallinga JW, Mensink RP, Baumgartner S, van de Heijning BJM, van Schooten FJ.

Sci Rep. 2019 Jan 24;9(1):554. doi: 10.1038/s41598-018-37210-5.

4.

Limited clinical value of exhaled volatile organic compound measurements in childhood asthma.

Fuglsbjerg MG, Rasmussen MA, Hansen KS, Smolinska A, Dallinga JW, van Schooten FJ, Stokholm J, Bønnelykke K, Bisgaard H, Chawes BL.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00026-2018. doi: 10.1183/23120541.00026-2018. eCollection 2018 Oct.

5.

Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles.

Rees CA, Nasir M, Smolinska A, Lewis AE, Kane KR, Kossmann SE, Sezer O, Zucchi PC, Doi Y, Hirsch EB, Hill JE.

Sci Rep. 2018 Sep 5;8(1):13297. doi: 10.1038/s41598-018-31543-x.

6.

Identification of Mycobacterium tuberculosis using volatile biomarkers in culture and exhaled breath.

Mellors TR, Nasir M, Franchina FA, Smolinska A, Blanchet L, Flynn JL, Tomko J, O'Malley M, Scanga CA, Lin PL, Wagner J, Hill JE.

J Breath Res. 2018 Oct 30;13(1):016004. doi: 10.1088/1752-7163/aacd18.

PMID:
29910196
7.

Volatile metabolites in breath strongly correlate with gut microbiome in CD patients.

Smolinska A, Tedjo DI, Blanchet L, Bodelier A, Pierik MJ, Masclee AAM, Dallinga J, Savelkoul PHM, Jonkers DMAE, Penders J, van Schooten FJ.

Anal Chim Acta. 2018 Sep 26;1025:1-11. doi: 10.1016/j.aca.2018.03.046. Epub 2018 Mar 30.

8.

Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.

Nasir M, Bean HD, Smolinska A, Rees CA, Zemanick ET, Hill JE.

Sci Rep. 2018 Jan 16;8(1):826. doi: 10.1038/s41598-017-18491-8.

9.

Exposure to genotoxic compounds alters in vitro cellular VOC excretion.

Fijten RRR, Smolinska A, Shi Q, Pachen DM, Dallinga JW, Boots AW, van Schooten FJ.

J Breath Res. 2018 Jan 3;12(2):027101. doi: 10.1088/1752-7163/aa9080.

PMID:
28972195
10.

The necessity of external validation in exhaled breath research: a case study of sarcoidosis.

Fijten RRR, Smolinska A, Drent M, Dallinga JW, Mostard R, Pachen DM, van Schooten FJ, Boots AW.

J Breath Res. 2017 Nov 29;12(1):016004. doi: 10.1088/1752-7163/aa8409.

PMID:
28775245
11.

Editorial: volatile organic compounds in breath for monitoring IBD-longitudinal studies are essential. Authors' reply.

Smolinska A, van Schooten FJ.

Aliment Pharmacol Ther. 2017 Aug;46(3):372. doi: 10.1111/apt.14163. No abstract available.

12.

The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis.

Smolinska A, Bodelier AG, Dallinga JW, Masclee AA, Jonkers DM, van Schooten FJ, Pierik MJ.

Aliment Pharmacol Ther. 2017 May;45(9):1244-1254. doi: 10.1111/apt.14004. Epub 2017 Feb 26.

13.

Factors that influence the volatile organic compound content in human breath.

Blanchet L, Smolinska A, Baranska A, Tigchelaar E, Swertz M, Zhernakova A, Dallinga JW, Wijmenga C, van Schooten FJ.

J Breath Res. 2017 Feb 22;11(1):016013. doi: 10.1088/1752-7163/aa5cc5.

PMID:
28140379
14.

Can exhaled volatile organic compounds predict asthma exacerbations in children?

van Vliet D, Smolinska A, Jöbsis Q, Rosias P, Muris J, Dallinga J, Dompeling E, van Schooten FJ.

J Breath Res. 2017 Mar 1;11(1):016016. doi: 10.1088/1752-7163/aa5a8b.

PMID:
28102830
15.

The fecal microbiota as a biomarker for disease activity in Crohn's disease.

Tedjo DI, Smolinska A, Savelkoul PH, Masclee AA, van Schooten FJ, Pierik MJ, Penders J, Jonkers DM.

Sci Rep. 2016 Oct 13;6:35216. doi: 10.1038/srep35216.

16.

A novel biomarker panel for irritable bowel syndrome and the application in the general population.

Mujagic Z, Tigchelaar EF, Zhernakova A, Ludwig T, Ramiro-Garcia J, Baranska A, Swertz MA, Masclee AA, Wijmenga C, van Schooten FJ, Smolinska A, Jonkers DM.

Sci Rep. 2016 Jun 6;6:26420. doi: 10.1038/srep26420.

17.

The volatile metabolome of Klebsiella pneumoniae in human blood.

Rees CA, Smolinska A, Hill JE.

J Breath Res. 2016 May 10;10(2):027101. doi: 10.1088/1752-7155/10/2/027101.

PMID:
27163334
18.

Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach.

Baranska A, Mujagic Z, Smolinska A, Dallinga JW, Jonkers DM, Tigchelaar EF, Dekens J, Zhernakova A, Ludwig T, Masclee AA, Wijmenga C, van Schooten FJ.

Aliment Pharmacol Ther. 2016 Jul;44(1):45-56. doi: 10.1111/apt.13654. Epub 2016 May 2.

19.

Association between exhaled inflammatory markers and asthma control in children.

Van Vliet D, Smolinska A, Jöbsis Q, Rosias PP, Muris JW, Dallinga JW, van Schooten FJ, Dompeling E.

J Breath Res. 2016 Feb 19;10(1):016014. doi: 10.1088/1752-7155/10/1/016014.

PMID:
26893372
20.

A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis.

Pijls KE, Smolinska A, Jonkers DM, Dallinga JW, Masclee AA, Koek GH, van Schooten FJ.

Sci Rep. 2016 Jan 29;6:19903. doi: 10.1038/srep19903.

21.

Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.

Schnabel R, Fijten R, Smolinska A, Dallinga J, Boumans ML, Stobberingh E, Boots A, Roekaerts P, Bergmans D, van Schooten FJ.

Sci Rep. 2015 Nov 26;5:17179. doi: 10.1038/srep17179.

22.

Data Fusion in Metabolomics and Proteomics for Biomarker Discovery.

Blanchet L, Smolinska A.

Methods Mol Biol. 2016;1362:209-23. doi: 10.1007/978-1-4939-3106-4_14.

PMID:
26519180
23.

Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures.

Baranska A, Smolinska A, Boots AW, Dallinga JW, van Schooten FJ.

J Breath Res. 2015 Oct 15;9(4):047102. doi: 10.1088/1752-7155/9/4/047102.

PMID:
26469548
24.

Electronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia.

Schnabel RM, Boumans ML, Smolinska A, Stobberingh EE, Kaufmann R, Roekaerts PM, Bergmans DC.

Respir Med. 2015 Nov;109(11):1454-9. doi: 10.1016/j.rmed.2015.09.014. Epub 2015 Sep 30.

25.

Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach.

Bodelier AG, Smolinska A, Baranska A, Dallinga JW, Mujagic Z, Vanhees K, van den Heuvel T, Masclee AA, Jonkers D, Pierik MJ, van Schooten FJ.

Inflamm Bowel Dis. 2015 Aug;21(8):1776-85. doi: 10.1097/MIB.0000000000000436.

PMID:
26199990
26.

Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age.

Klaassen EM, van de Kant KD, Jöbsis Q, van Schayck OC, Smolinska A, Dallinga JW, van Schooten FJ, den Hartog GJ, de Jongste JC, Rijkers GT, Dompeling E.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):201-7. doi: 10.1164/rccm.201408-1537OC.

PMID:
25474185
27.
28.

Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.

Dallinga JW, Smolinska A, van Schooten FJ.

Methods Mol Biol. 2014;1198:251-63. doi: 10.1007/978-1-4939-1258-2_16.

PMID:
25270934
29.

Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.

Smolinska A, Klaassen EM, Dallinga JW, van de Kant KD, Jobsis Q, Moonen EJ, van Schayck OC, Dompeling E, van Schooten FJ.

PLoS One. 2014 Apr 21;9(4):e95668. doi: 10.1371/journal.pone.0095668. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105447.

30.

Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry.

Boots AW, Smolinska A, van Berkel JJ, Fijten RR, Stobberingh EE, Boumans ML, Moonen EJ, Wouters EF, Dallinga JW, Van Schooten FJ.

J Breath Res. 2014 Jun;8(2):027106. doi: 10.1088/1752-7155/8/2/027106. Epub 2014 Apr 16.

PMID:
24737039
31.

Current breathomics--a review on data pre-processing techniques and machine learning in metabolomics breath analysis.

Smolinska A, Hauschild AC, Fijten RR, Dallinga JW, Baumbach J, van Schooten FJ.

J Breath Res. 2014 Jun;8(2):027105. doi: 10.1088/1752-7155/8/2/027105. Epub 2014 Apr 8. Review.

PMID:
24713999
32.

Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet.

Baranska A, Tigchelaar E, Smolinska A, Dallinga JW, Moonen EJ, Dekens JA, Wijmenga C, Zhernakova A, van Schooten FJ.

J Breath Res. 2013 Sep;7(3):037104. doi: 10.1088/1752-7155/7/3/037104. Epub 2013 Jun 18.

PMID:
23774130
33.

NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review.

Smolinska A, Blanchet L, Buydens LM, Wijmenga SS.

Anal Chim Acta. 2012 Oct 31;750:82-97. doi: 10.1016/j.aca.2012.05.049. Epub 2012 Jun 9. Review.

PMID:
23062430
34.

Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.

Smolinska A, Blanchet L, Coulier L, Ampt KA, Luider T, Hintzen RQ, Wijmenga SS, Buydens LM.

PLoS One. 2012;7(6):e38163. doi: 10.1371/journal.pone.0038163. Epub 2012 Jun 8.

35.

The versatile use of exhaled volatile organic compounds in human health and disease.

Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ.

J Breath Res. 2012 Jun;6(2):027108. doi: 10.1088/1752-7155/6/2/027108. Epub 2012 May 23. Review.

PMID:
22621865
36.

Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion.

Smolinska A, Posma JM, Blanchet L, Ampt KA, Attali A, Tuinstra T, Luider T, Doskocz M, Michiels PJ, Girard FC, Buydens LM, Wijmenga SS.

Anal Bioanal Chem. 2012 May;403(4):947-59. doi: 10.1007/s00216-012-5871-4. Epub 2012 Mar 7.

37.

The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid.

Rosenling T, Stoop MP, Smolinska A, Muilwijk B, Coulier L, Shi S, Dane A, Christin C, Suits F, Horvatovich PL, Wijmenga SS, Buydens LM, Vreeken R, Hankemeier T, van Gool AJ, Luider TM, Bischoff R.

Clin Chem. 2011 Dec;57(12):1703-11. doi: 10.1373/clinchem.2011.167601. Epub 2011 Oct 13.

38.

NMR and pattern recognition can distinguish neuroinflammation and peripheral inflammation.

Smolinska A, Attali A, Blanchet L, Ampt K, Tuinstra T, van Aken H, Suidgeest E, van Gool AJ, Luider T, Wijmenga SS, Buydens LM.

J Proteome Res. 2011 Oct 7;10(10):4428-38. doi: 10.1021/pr200203v. Epub 2011 Aug 26.

PMID:
21806074
39.

Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis.

Blanchet L, Smolinska A, Attali A, Stoop MP, Ampt KA, van Aken H, Suidgeest E, Tuinstra T, Wijmenga SS, Luider T, Buydens LM.

BMC Bioinformatics. 2011 Jun 22;12:254. doi: 10.1186/1471-2105-12-254.

40.

Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.

Stoop MP, Coulier L, Rosenling T, Shi S, Smolinska AM, Buydens L, Ampt K, Stingl C, Dane A, Muilwijk B, Luitwieler RL, Sillevis Smitt PA, Hintzen RQ, Bischoff R, Wijmenga SS, Hankemeier T, van Gool AJ, Luider TM.

Mol Cell Proteomics. 2010 Sep;9(9):2063-75. doi: 10.1074/mcp.M900877-MCP200.

41.

Analysis of correlations between the occurrence of anti-MAP antibodies in blood serum and the presence of DNA-MAP in milk.

Wiszniewska-Łaszczych A, Szteyn J, Smolińska A.

Pol J Vet Sci. 2009;12(3):379-83.

PMID:
19886260

Supplemental Content

Loading ...
Support Center